ESMO 2019 — Overview of Presidential Symposium III: GI and GU cancer


  • Ben Gallarda
  • Oncology Conference reports
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

The third Presidential Symposium of ESMO 2019 included results with targeted therapies in cholangiocarcinoma and prostate cancer, and immunotherapy for oesophageal and urothelial carcinoma.

Takeaways